Journals

Cost-Effectiveness of New and Emerging Treatment Options for the Treatment of Metastatic Colorectal Cancer
Supplements > Managing the Evolving Landscape of Metastatic Colorectal Cancer
Jennifer Zadlo, PharmD, BCOP
Posttest
Supplements > Managing the Evolving Landscape of Metastatic Colorectal Cancer
Participating Faculty
Supplements > Managing the Evolving Landscape of Metastatic Colorectal Cancer
The Evolution of Biomarkers to Guide the Treatment of Metastatic Colorectal Cancer
Supplements > Managing the Evolving Landscape of Metastatic Colorectal Cancer
Lisa E. Davis, PharmD, FCCP, BCPS, BCOP
Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
Supplements > Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
Benjamin Rix Brooks, MD; James A. Jorgenson, MS, RPh, FASHP; Barbara J. Newhouse, MS, BSW; Jeremy M. Shefner, MD, PhD; and Wendy Agnese, PharmD
Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix
Supplements > Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
Benjamin Rix Brooks, MD; James A. Jorgenson, MS, RPh, FASHP; Barbara J. Newhouse, MS, BSW; Jeremy M. Shefner, MD, PhD; and Wendy Agnese, PharmD
Participating Faculty
Supplements > Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion
From the Editor in Chief: A Game of Risk
Evidence-Based Oncology > April 2018
Joseph Alvarnas, MD
Medical World News: Managed Care Updates
Evidence-Based Oncology > April 2018
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!